Vor Biopharma Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $299.4M
Liabilities Breakdown FY2022
Total Liabilities: $48.8M
Asset Breakdown
Total Assets: $299.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $57.7M | 19.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $12.6M | 4.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $229.0M | 76.5% |
Liabilities Breakdown
Total Liabilities: $48.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.8M | 3.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $47.0M | 96.4% |